发明授权
US06569858B2 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbazole and 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]carbazoles
失效
12,13-(吡喃糖基) - 吲哚并[2,3-a]吡咯并[3,4-c]咔唑和12,13-(吡喃糖基) - 呋喃并[3,4-c]吲哚并[2,3-a] 咔唑
- 专利标题: 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbazole and 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]carbazoles
- 专利标题(中): 12,13-(吡喃糖基) - 吲哚并[2,3-a]吡咯并[3,4-c]咔唑和12,13-(吡喃糖基) - 呋喃并[3,4-c]吲哚并[2,3-a] 咔唑
-
申请号: US10010379申请日: 2001-11-05
-
公开(公告)号: US06569858B2公开(公告)日: 2003-05-27
- 发明人: Michelle Prudhomme , Pascale Moreau , Fabrice Anizon , Christelle Marminon , Ghanem Atassi , Alain Pierre , Bruno Pfeiffer , Pierre Renard
- 申请人: Michelle Prudhomme , Pascale Moreau , Fabrice Anizon , Christelle Marminon , Ghanem Atassi , Alain Pierre , Bruno Pfeiffer , Pierre Renard
- 优先权: FR9914433 19991117
- 主分类号: C07D49044
- IPC分类号: C07D49044
摘要:
A compound selected from those of formula (I): wherein: R1 and R2, which may be identical or different, represent a group of formula U-V wherein U represents single bond, or alkylene which is optionally substituted and/or unsaturated, and V is as defined in the description, G represents oxygen, or NR3 wherein R3 is as defined in the description, X represents hydrogen, hydroxy, alkoxy, mercapto or alkylthio, Y represents hydrogen, or X+Y represents carbonyl, X1 represents hydrogen, hydroxy, alkoxy, mercapto or alkylthio, Y1 represents hydrogen, or X1+Y1 represents carbonyl, R4, R5, and R6 are as defined in the description, its isomers, and pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same are useful in the treatment of cancer.
公开/授权文献
信息查询